Agios Pharmaceuticals
AGIO
#5073
Rank
S$2.15 B
Marketcap
S$37.01
Share price
3.35%
Change (1 day)
-18.76%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: S$2.15 Billion

As of January 2026 Agios Pharmaceuticals has a market cap of S$2.15 Billion. This makes Agios Pharmaceuticals the world's 5073th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$2.15 B2.87%
2025S$2.09 B-18.98%
2024S$2.58 B57.5%
2023S$1.64 B-20.52%
2022S$2.06 B-14.29%
2021S$2.41 B-39.21%
2020S$3.97 B-9.84%
2019S$4.40 B20.07%
2018S$3.66 B-1.63%
2017S$3.72 B46.91%
2016S$2.53 B-26.7%
2015S$3.46 B-36.97%
2014S$5.49 B480.1%
2013S$0.94 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Agios Pharmaceuticals was reported to be:

S$2.15 Billion
by Nasdaq info icon info icon
S$2.15 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Xencor
XNCR
S$1.32 B-38.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$15.68 B 626.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$187.33 B 8,581.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$13.87 B 543.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$132.21 B 6,026.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Eli Lilly
LLY
S$1.239 T 57,330.08%๐Ÿ‡บ๐Ÿ‡ธ USA